Pax Labs Inc. Sues Stiiizy Inc. and ALD Group Ltd. for Patent Infringement

Regulations by 2FIRSTS.ai

Jan.31.2024

Pax Labs Inc. Sues Stiiizy Inc. and ALD Group Ltd. for Patent Infringement

Pax Labs Inc. has filed a lawsuit against Stiiizy Inc. and ALD Group Ltd. for patent infringement regarding e-cigarette devices.

Pax Labs Inc., an e-cigarette manufacturer, has filed a lawsuit against its competitor Stiiizy Inc. and its producer ALD Group Ltd. for alleged patent infringement, as reported by Bloomberg on January 30th.

This lawsuit was filed in the Central District of California District Court in the United States. Pax Labs alleges that Stiiizy and ALD, based in Hong Kong, China, have been manufacturing and selling vaporization devices, including batteries and pods, in a manner similar to Pax Labs' patented technology.

Pax Labs has obtained US patents 11,369,756, 11,369,757, 11,766,527, and 11,759,580, which pertain to methods for leak prevention in pods and related devices. Pax Labs alleges that the aforementioned companies have infringed upon these patents.

Pax Labs, a former developer of the Juule-cigarette, has spun off Juul as a separate subsidiary.

References:

[1] Stiiizy, ALD Group Sued Over Patents for Vaping Pen Technology

Also Read:

[1] Pitt County School District Joins Lawsuit Against Juul Labs

[2] Investors Question JUUL Board Members over Financial Distress in November 2022

[3] JUUL Labs Seeks FDA Authorization for Mint Flavored E-Cigarette Pods

[4] Juul Labs Raises $1.27 Billion in Equity Financing

#Law enforcement #North America #United States #Open system e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split

The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.

Nov.18 by 2FIRSTS.ai

State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.

State Tobacco Monopoly Administration director Zhang Jianmin met with Korean Tobacco Company president Fang Jingwan in Beijing on October 31.

Nov.03 by 2FIRSTS.ai

Tunisia's tobacco control policies are insufficiently implemented; experts call for the introduction of less harmful alternatives to help quit smoking

Although Tunisia has joined the WHO Framework Convention on Tobacco Control and implemented policies such as smoking bans and advertising restrictions, insufficient enforcement means nearly half of all men still smoke, with youth being particularly vulnerable. Public health experts recommend that Tunisia learn from the experiences of Sweden and the United Kingdom, introduce less harmful alternatives, and establish a customized regulatory system.

Sep.30 by 2FIRSTS.ai

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.